Lyon Street Capital’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
2018
Q4
$1.24M Sell
2018
Q3
$2.54M Sell
2018
Q2
$6.63M Sell
2018
Q1
$6.79M Buy
2017
Q4
$5.44M Buy